Literature DB >> 12759763

Hemangiopericytoma: a rare head and neck tumor.

Sven Koscielny1, Bernd Bräuer, Gerhard Förster.   

Abstract

Among the rare malignant tumors of the paranasal sinuses and the middle ear, the hemangiopericytoma represents a very rare tumor entity. Reviewing four cases treated in our ENT department, we present here our experiences with this tumor. Inpatient and outpatient medical records from 1976 to 2001 were evaluated retrospectively. For the whole period we found four patients, three women and one man, who were treated with the diagnosis of hemangiopericytoma. Three tumors were localized in the paranasal sinuses (two in the maxillary sinus, one in the frontal sinus) and one in the middle ear. While the two tumors of the maxillary sinus and the tumor of the middle ear were treated only by surgery, the patient with the tumor of the frontal sinus also received postoperative irradiation because of an endocranial infiltration. This patient was the only one who developed an endocranial recurrence 14 years later on the opposite site, which again was treated with a combination of surgery and radiotherapy. The hemangiopericytoma as a very rare tumor in the paranasal sinuses and the middle ear should be treated with surgery. In our view, an adjuvant radiotherapy is indicated only in selected individual cases.

Entities:  

Mesh:

Year:  2003        PMID: 12759763     DOI: 10.1007/s00405-003-0625-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  HEMANGIOPERICYTOMA.

Authors:  P O'BRIEN; R D BRASFIELD
Journal:  Cancer       Date:  1965-02       Impact factor: 6.860

2.  HEMANGIOPERICYTOMA: A VASCULAR TUMOR FEATURING ZIMMERMANN'S PERICYTES.

Authors:  A P Stout; M R Murray
Journal:  Ann Surg       Date:  1942-07       Impact factor: 12.969

3.  Cerebral haemangiopericytoma treated with conservative surgery and radiotherapy.

Authors:  J H Rees; N D Kitchen; R P Beaney; M Brada
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

4.  Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases.

Authors:  P J Catalano; M Brandwein; D K Shah; M L Urken; W Lawson; H F Biller
Journal:  Head Neck       Date:  1996 Jan-Feb       Impact factor: 3.147

Review 5.  Hemangiopericytoma of the maxillary sinus and skull base.

Authors:  H M Abdel-Fattah; G L Adams; M R Wick
Journal:  Head Neck       Date:  1990 Jan-Feb       Impact factor: 3.147

Review 6.  [Tumors and pseudotumors ("tumor-like lesions") of the frontal cranial base, originating in the nose, the paranasal sinuses and the nasopharynx (including surgical approach)].

Authors:  W Draf; A Berghaus
Journal:  Eur Arch Otorhinolaryngol Suppl       Date:  1993

7.  A 20-year review of haemangiopericytoma in Auckland, New Zealand.

Authors:  M F Borg; C S Benjamin
Journal:  Clin Oncol (R Coll Radiol)       Date:  1994       Impact factor: 4.126

8.  Proliferation index as a prognostic marker in hemangiopericytoma of the head and neck.

Authors:  P J Kowalski; A F Paulino
Journal:  Head Neck       Date:  2001-06       Impact factor: 3.147

9.  Hemangiopericytoma. An analysis of 106 cases.

Authors:  F M Enzinger; B H Smith
Journal:  Hum Pathol       Date:  1976-01       Impact factor: 3.466

  9 in total
  3 in total

1.  Hemangiopericytoma of the neck.

Authors:  Paraskevi Tsirevelou; Paschalis Chlopsidis; Ifigenia Zourou; Dimitrios Valagiannis; Charalampos Skoulakis
Journal:  Head Face Med       Date:  2010-09-24       Impact factor: 2.151

2.  Hemangiopericytoma: Conducts and perioperative management of an extent sinonasal tumor in a Jehovah's Witnesses patient - Case report.

Authors:  Francisco S Amorim Filho; Flávio M Gripp; Guilherme S Faria; Mateus Capuzzo Gonçalves; Lincoln Miyahira
Journal:  Cancer Rep (Hoboken)       Date:  2022-02-23

3.  Synchronous papillary carcinoma and hemangiopericytoma with lung metastases.

Authors:  Nicola Malagutti; Valeria Iannini; Andrea Rocchi; Francesco Stomeo; Antonio Frassoldati; Michela Borin; Stefano Pelucchi
Journal:  Case Rep Otolaryngol       Date:  2013-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.